REG - Belluscura PLC Tekcapital plc - Holding(s) in Company

TekcapitalAnnouncement

31/10/2022 18:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221031:nRSe8080Ea&default-theme=true

RNS Number : 8080E  Belluscura PLC  31 October 2022

31 October 2022

 

Belluscura PLC

("Belluscura" or the "Company")

 

Notification of Major Holding

 

Belluscura PLC (AIM: BELL), a leading medical device developer focused on
lightweight and portable oxygen enrichment technology, announces that the
Company has received notification that Tekcapital Plc has reduced its holding
from 13.932% to 12.3062% of the total voting rights of the Company.
TekCapital Plc and now holds 15,138,767 Belluscura ordinary shares of 1p each.

 

The share sale was undertaken on 28 October 2022 by Dowgate Capital who have
placed the shares with new and existing shareholders. Tekcapital Plc has
undertaken that they will not sell any further shares in Belluscura for a
minimum period of six months following the share placing, unless both the
Company and Dowgate Capital consent to any such share disposals.

 

 

 

 Belluscura plc                               www.belluscura.com (http://www.belluscura.com)
 Robert Rauker, Chief Executive Officer       via MHP Communications
 Anthony Dyer, Chief Financial Officer

 SPARK Advisory Partners Ltd                  Tel: +44 (0)20 3368 3550

(Nominated Adviser)
 Neil Baldwin

 Dowgate Capital Ltd                          Tel: +44 (0)20 3903 7715

(Broker)
 James Serjeant / Nicholas Chambers

 MHP Communications                           Tel: +44 (0)20 3128 8100
 (Media & Investor Relations)                 or belluscura@mhpc.com (mailto:belluscura@walbrookpr.com)
 Katie Hunt / Pete Lambie / Matthew Taylor

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLDFLFXLBLZFBL